Entera Bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	0	0.13	0.57	0.37	0.24	0.5	0	0
Revenue Growth (YoY)	-	-76.53%	56.44%	54.66%	-52.80%	-	-	-
Cost of Revenue	0	0.1	0.37	0.3	0.21	0	0	0
Gross Profit	0	0.03	0.2	0.07	0.03	0.5	0	0
Selling, General & Admin	4.43	7.25	5.69	4.85	4.28	2.84	8.58	2.72
Research & Development	4.51	5.85	6.77	6.38	7.2	8.52	2.77	2.65
Operating Expenses	8.94	13.1	12.46	11.23	11.48	11.36	11.34	5.37
Operating Income	-8.94	-13.07	-12.26	-11.17	-11.45	-10.86	-11.34	-5.37
Other Expense / Income	-0.08	-0.13	-0.02	0.03	-0.66	-0.56	-0.15	-4.17
Pretax Income	-8.86	-12.93	-12.25	-11.2	-10.8	-10.3	-11.2	-1.2
Income Tax	0.03	0.14	-0.06	0.02	0	0	0	0
Net Income	-8.89	-13.07	-12.19	-11.22	-10.8	-10.3	-11.2	-1.2
Shares Outstanding (Basic)	29	29	26	18	12	8	4	4
Shares Outstanding (Diluted)	29	29	26	18	12	8	4	7
Shares Change	0.69%	10.23%	41.90%	51.62%	52.15%	77.78%	-33.53%	-
EPS (Basic)	-0.31	-0.45	-0.47	-0.67	0.89	1.30	2.49	0.27
EPS (Diluted)	-0.31	-0.45	-0.47	-0.67	0.89	1.31	2.49	0.78
EPS Growth	-	-	-	-	-32.06%	-47.39%	219.23%	-
Free Cash Flow	-7.33	-12.55	-9.08	-10.61	-8.96	-9.86	-4.58	-3.18
Free Cash Flow Per Share	-0.25	-0.44	-0.35	-0.58	-0.74	-1.24	-1.02	-0.71
Gross Margin	-	24.63%	34.68%	17.81%	11.02%	100.00%	-	-
Operating Margin	-	-9752.24%	-2147.64%	-3059.73%	-4853.39%	-2172.20%	-	-
Profit Margin	-	-9754.48%	-2134.33%	-3072.88%	-4574.15%	-2060.80%	-	-
Free Cash Flow Margin	-	-9362.69%	-1590.19%	-2906.85%	-3796.19%	-1972.80%	-	-
EBITDA	-8.8	-12.87	-12.19	-11.13	-10.56	-10.25	-11.15	-1.16
EBITDA Margin	-	-9604.48%	-2135.38%	-3050.14%	-4473.31%	-2050.00%	-	-
Depreciation & Amortization	0.06	0.06	0.05	0.06	0.24	0.05	0.04	0.04
EBIT	-8.86	-12.93	-12.25	-11.2	-10.8	-10.3	-11.2	-1.2
EBIT Margin	-	-9652.24%	-2144.66%	-3067.40%	-4574.15%	-2060.80%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).